Status:
COMPLETED
Cirrhotics Undergoing General Surgery
Lead Sponsor:
Danny Lascano
Conditions:
Cirrhosis, Liver
Eligibility:
All Genders
18+ years
Brief Summary
Surgery on cirrhotic patients represents a clinical challenge but intervening before these patients develop complications can prolong the likelihood of these patients making it to transplant for those...
Detailed Description
Introduction The incidence of cirrhosis is increasing as alcoholic liver disease overtakes hepatitis as the cause of cirrhosis although it will likely stabilize as Hepatitis C treatment makes its way...
Eligibility Criteria
Inclusion
- All non-transplant surgical procedures by the principal investigator over a 5-year period (2013-2018)
- Patients with a known, symptomatic and documented pre-operative history of cirrhosis
Exclusion
- Asymptomatic or incidentally discovered cirrhosis
Key Trial Info
Start Date :
June 27 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2019
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT05202457
Start Date
June 27 2017
End Date
June 30 2019
Last Update
January 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Westchester Medical Center
Valhalla, New York, United States, 10595